AbbVie has substantially cut the price of its newly approved hepatitis C drug to win an exclusive deal with Express Scripts, the nation's largest manager of prescription drug benefits, the companies said Monday.
Ellen Jean Hirst, Chicago Tribune
Mon, 12/22/2014 - 12:15pm
AbbVie has substantially cut the price of its newly approved hepatitis C drug to win an exclusive deal with Express Scripts, the nation's largest manager of prescription drug benefits, the companies said Monday.